Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cigarette 2 is an experimental nicotine-delivery intervention used in clinical research conducted by the University of Southern California. Specifically utilized in studies exploring the intersection of obsessive-compulsive disorder (OCD) symptoms and tobacco dependence, this intervention involves cigarettes with controlled nicotine content, ranging from 0 mg to a standard level of 0.8 mg. The primary objective of using these cigarettes in a research setting is to evaluate the behavioral and physiological mechanisms of nicotine addiction and withdrawal under varying levels of exposure. By manipulating nicotine dosage, researchers can observe how different levels of the drug interact with psychiatric symptoms to influence smoking behavior.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cigarette 2.